Drug Trial Radar · NCT05391022
Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies
Last checked: Nov 19, 2026Latest source record: Jul 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
35
Actual
Start
Jul 20, 2021
Primary completion
Mar 8, 2023
Study completion Feb 29, 2024
Sponsor
- Lead sponsor
- Constellation PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- May 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 1 2-part study to evaluate the effect of food on pharmacokinetics of pelabresib (CPI-0610) and the effect of pelabresib on QTc in patients with advanced malignancies
Conditions
- Advanced Malignancies
- Solid Tumor
- Hematological Malignancy
Interventions
PelabresibDrug
Pelabresib monohydrate tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Run-In Food Effect Period: Area under the concentration time curve (AUC) based on pelabresib concentrations in plasma measured using validated plasma assayTime frame: 21 days
- Run-In Food Effect Period: maximal plasma concentration (Cmax) based on pelabresib concentrations in plasma measured using validated plasma assayTime frame: 21 days
- Run-In Food Effect Period: Time to maximal plasma concentration (Tmax) based on pelabresib concentrations in plasma measured using validated plasma assayTime frame: 21 days
- Continuous Treatment Period: Changes in QT and QTc intervalsTime frame: 12 months
Locations
10 sites in 3 countries. Site status is shown where the registry gives one.
Gabrail Cancer Center Research
Canton, Ohio
Gettysburg Cancer Center
Gettysburg, Pennsylvania
Start Mountain Region
West Valley City, Utah
Hight Technology Hospital Medcenter
Batumi, Georgia
K. Eristavi National Center of Experimental and Clinical Surgery
Tbilisi, Georgia
Simon Khechinashvili University Hospital
Tbilisi, Georgia
Barcelona HM Nou Delfos
Barcelona, Spain
Madrid - FJD
Madrid, Spain
START CIOCC Hospital HM Sanchinarro
Madrid, Spain
Hospital Universitario Virgen del Rocío
Seville, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.